Sinclair IS Pharma Share Price (SPH)

31.05 +0.05 (+0.16%) delayed: 12:01PM BST
Bid price 31.00 Open price 31.01
Ask price 31.10 Prev close 31.00
High price 31.10 Spread 0.32%
Low price 31.00 Volume 480,704

Register now for FREE live Sinclair IS Pharma share prices, Sinclair IS Pharma stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get Sinclair IS Pharma Level 2 Data, indepth research tools and investor commentary for Sinclair IS Pharma (SPH) and other London Stock Exchange equities.

Sinclair IS Pharma Share Price Chart

Advanced Charts >>

Register now for FREE Sinclair IS Pharma share price charts

Sinclair IS Pharma Share Price Information

Name Sinclair IS Pharma Epic SPH
Sector Pharmaceuticals & Biotechnology ISIN GB0033856740
Activites Sinclair Pharma plc (formerly Sinclair IS Pharma plc, formerly Sinclair Pharma plc) is an international company operating in the fast growth, high gross margin, global aesthetics market. Sinclair has built a strong portfolio of differentiated, complementary aesthetics technologies, which are experiencing significant growth, targeting unmet clinical needs for effective, high quality, longer duration, natural looking and minimally-invasive treatments. Sinclair is planning entry to multiple new geographic markets and line extension launches over the next few years. The Group has an established sales and marketing presence in the leading EU markets and Brazil, and a network of international distributors including ThermiGen in the US. Index n/a

Sinclair IS Pharma Key Numbers

Latest Share Price (p) 31.05 Net Gearing (%) 40.18
Market Capitalisation (£m) 156.17 Gross Gearing (%) 41.27
Shares in issue (m) 503.77 Debt Ratio 33.31
P/E Ratio -3,100.00 Debt-to-Equity Ratio 0.71
Total dividends per share (p) 0.00 Assets / Equity Ratio 1.70
Dividend Yield (%) 0.00 Price to book value 1.57
Dividend cover (x) 0.00 ROCE (%) -2.92
Earning per share (p) -0.01 EPS Growth (%) 99.83
52 week high / low 31.20 / 14.45 DPS Growth (%) n/a

Sinclair IS Pharma Director Deals

Dec.Date Type Director Pos No. of Shares
17/01/2018 BUY Jeff Thompson NED 200,000
16/01/2018 BUY Christopher Spooner CEO 200,000
05/10/2016 BUY Jeff Thompson NED 150,000
31/05/2016 BUY Jean-Charles Tschudin NED 3,023
31/05/2016 BUY Jean-Charles Tschudin NED 97,000

More Sinclair IS Pharma Director Deals >>

Sinclair IS Pharma Company News

12:00 26/09/2018

Form 8.5 (EPT/RI) - Sinclair Pharma Plc

RNS Number : 9973B Peel Hunt LLP 26 September 2018   FORM 8.5 (EPT/RI)   PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code")   1....

14:46 25/09/2018

Form 8.3 - Sinclair Pharma plc

Form 8.3 - Sinclair Pharma plc Litespeed Management LLC FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR...

12:00 25/09/2018

Form 8.5 (EPT/RI) - Sinclair Pharma Plc

RNS Number : 8502B Peel Hunt LLP 25 September 2018   FORM 8.5 (EPT/RI)   PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code")   1....

More Sinclair IS Pharma Company News >>

Register now for FREE Sinclair IS Pharma company news

Sinclair IS Pharma Share Price Discussions

3 months ago

Bargain shares - but only for Directors! (SPH)

However, you read it, the News today that Dir have been given shares at 1p when the Market mid is 28p looks like something out of the book "They never told such a story, you dreamt it" So just what performance does such largess reward, I wonder? Ah yes, the sp has increased 10-fold, ah so....

more than 1 year ago

Take over bid rejected (SPH)

News article which appears to have gone unnoticed. From "THIS IS MONEY" website Ubiquitious Warburg Pincus has completed more initial public offerings (IPOs) than any other private equity firm. It is currently putting its considerable weight behind a proposed $1.5bn IPO of Bausch & Lomb,...

more than 1 year ago

Trading update due July (SPH)

Year end 30th June and a trading update out early July. A couple of Funds have been topping up in recent weeks. 62.5% of shares now with investment funds plus another 3.42% with directors.

Register now for FREE Sinclair IS Pharma share price discussions